Document is current
Any future updates will be listed below
-
Authors
Manica, Santiago Rodrigues http://orcid.org/0000-0002-7217-0469
Sepriano, Alexandre
Pimentel-Santos, Fernando
Gouveia, Nélia
Barcelos, Anabela
Branco, Jaime C.
Bernardes, Miguel
Ferreira, Raquel Miriam
Vieira-Sousa, Elsa
Barreira, Sofia
Vinagre, Filipe
Roque, Raquel
Santos, Helena
Madeira, Nathalie
Rovisco, João
Daniel, Alexandra
Ramiro, Sofia
-
Funding
Funding for this research was provided by:
Merck Sharp and Dohme (IIS# 57763)
Fundação para a Ciência e a Tecnologia (SFRH/BD/108246/2015)
- License Information
-
More Information
Article History
Received: 27 April 2020
Accepted: 7 August 2020
First Online: 21 August 2020
Ethics approval and consent to participate
: Reuma.pt has been approved by the ethics committees of the participating hospitals and complies with the Declaration of Helsinki. This specific study has been approved by the ethics committee of the NOVA Medical School, Lisbon, Portugal. Patients have signed a written informed consent before inclusion.
: Not applicable
: SRM: honoraria as a speaker—Janssen, NovartisAS: honoraria as a speaker—NovartisSR: consulting and/or speaking fees—AbbVie, Eli Lilly, MSD, Novartis, Pfizer, Sanofi, and UCBAB: consulting and/or speaking fees—AbbVie, Eli Lilly, MSD, Novartis, and Pfizer
